Association of kidney function with inflammatory and procoagulant markers in a diverse cohort: a cross-sectional analysis from the Multi-Ethnic Study of Atherosclerosis (MESA).
about
Venous thromboembolism in chronic kidney disease: epidemiology, the role of proteinuria, CKD severity and therapeutics.Physical performance and frailty in chronic kidney diseaseChronic kidney disease and venous thromboembolism: epidemiology and mechanisms.Soluble TNF receptors and kidney dysfunction in the elderly.Chronic Kidney Dysfunction Can Increase the Risk of Deep Vein Thrombosis after Total Hip and Knee Arthroplasty.Markers of inflammation, coagulation, and renal function are elevated in adults with HIV infectionPrevalence of kidney disease in anaemia differs by GFR-estimating method: the Third National Health and Nutrition Examination Survey (1988-94).Prospective evaluation of bone markers, parathormone and 1,25-(OH)₂ vitamin D in HIV-positive patients after the initiation of tenofovir/emtricitabine with atazanavir/ritonavir or efavirenz.Inflammation and renal function after a four-year follow-up in subjects with unimpaired glomerular filtration rate: results from the observational, population-based CARLA cohortHeritability of renal function and inflammatory markers in adult male twinsEstimated glomerular filtration rate is a poor predictor of the concentration of middle molecular weight uremic solutes in chronic kidney diseaseInflammation, oxidative stress, glomerular filtration rate, and albuminuria in elderly men: a cross-sectional study.Exercise electrocardiographic responses and serum cystatin C levels among metabolic syndrome patients without overt diabetes mellitus.Rosuvastatin preserves renal function and lowers cystatin C in HIV-infected subjects on antiretroviral therapy: the SATURN-HIV trial.Inflammation, kidney function and albuminuria in the Framingham Offspring cohort.Racial differences in the association of pentraxin-3 with kidney dysfunction: the Multi-Ethnic Study of Atherosclerosis.Elevation of circulating TNF receptors 1 and 2 increases the risk of end-stage renal disease in American Indians with type 2 diabetes.Circulating TNF receptors 1 and 2 are associated with the severity of renal interstitial fibrosis in IgA nephropathy.Cystatin C, renal function, and atherosclerosis in rheumatoid arthritisThrombosis in the uremic milieu--emerging role of "thrombolome".Association of C-reactive protein, tumor necrosis factor-alpha, and interleukin-6 with chronic kidney diseaseReductions in Plasma Cystatin C After Initiation of Antiretroviral Therapy Are Associated With Reductions in Inflammation: ACTG A5224s.Circulating Tumor Necrosis Factor α Receptors Predict the Outcomes of Human IgA Nephropathy: A Prospective Cohort Study.Cystatin C is associated with inflammation but not atherosclerosis in systemic lupus erythematosus.Circulating TNF receptors 1 and 2 predict ESRD in type 2 diabetesSoluble Tumor Necrosis Factor Receptor 1 Is Associated with Glomerular Filtration Rate Progression and Incidence of Chronic Kidney Disease in Two Community-Based Cohorts of Elderly Individuals.The ethnicity-specific association of biomarkers with the angiographic severity of coronary artery disease.Epigenetic markers of renal function in african americans.Management of Atrial Fibrillation in Patients With Kidney Disease.TCDD-induced cyclooxygenase-2 expression is mediated by the nongenomic pathway in mouse MMDD1 macula densa cells and kidneys.The Relationship Between Atrial Fibrillation and Chronic Kidney Disease : Epidemiologic and Pathophysiologic Considerations for a Dual Epidemic.Critical role of CXCL16 in hypertensive kidney injury and fibrosis.Plasma apolipoprotein L1 levels do not correlate with CKD.The Role of Inflammatory Processes in Occurrence of Left Ventricular Failure in Patients with Chronic Kidney Disease.Gene polymorphisms of interleukin-17 and interleukin-17 receptor are associated with end-stage kidney disease.Fast renal decline to end-stage renal disease: an unrecognized feature of nephropathy in diabetes.Effect of renal function on whole blood and fibrin clot formation in atrial fibrillation patients on warfarin.Atrial fibrillation and chronic kidney disease: focus on rivaroxaban.Analysis of biomarkers for risk of acute kidney injury after primary angioplasty for acute ST-segment elevation myocardial infarction: results of the HORIZONS-AMI trial.Cystatin C levels in plasma and peripheral blood mononuclear cells among hyperhomocysteinaemic subjects: effect of treatment with B-vitamins.
P2860
Q30244606-6A33588F-856B-45B3-9889-C9DEE4B2E1CFQ33604462-C719E6E6-35E6-45B3-8BD7-27C4DCB713BAQ33610908-3BDE59DF-EE06-4E6D-A7C9-554B6DFDD59DQ33660677-546E4B1D-E2C3-4DCB-A945-3A94680A7340Q33762513-67A229DA-CD04-4515-8146-5967ED5E0B15Q33857515-1D40175B-31F8-45EC-85C3-2D20BAA3EF41Q34021375-2624CF34-E114-43BD-89DC-5334FA017CFCQ34158739-D66C59B3-20F4-4B46-A28F-BA21DC0EEAE7Q34258668-8B3671FA-2959-4129-B917-8F5277FBD7F6Q34307344-B97C1399-7EEF-455E-B979-D8B13F9DAF42Q34406428-B6D4445C-7EA2-453A-834F-7FAE9429510CQ34422837-0211AFE2-7076-41F1-856F-F64CF3BC7E50Q34627702-0FFE002A-B88F-4B9F-8939-93D14D76EC98Q34736818-0231F300-C3FD-433A-991A-43151E4B8C46Q35025400-F71E371B-AEFE-4220-B763-42BAC6F743C8Q35133148-8BDA4DF8-A349-49C0-AB70-6F84B1A515EFQ35243559-753FDEB3-3BD8-4C9D-B326-88B27826D198Q35364638-1C75A6BB-B1EE-415D-8789-7CB306D5AB20Q35511202-546F697C-C85E-4E5D-B5E6-19A78D9EF802Q35532702-7248B554-9323-400C-A1E9-49622E433C97Q35646625-5D000400-27EA-4CFA-AA4C-B5776BC36E17Q35652795-04E9FC75-F55D-468B-B59E-004BDE82C9D7Q35692544-3BAE78C7-F92F-490B-8EC6-1E9BD8E7C8A0Q35746107-BBAD3DE8-A24D-4184-AABD-606E3D411E9AQ35804201-F270EB8C-D4C5-41FE-84F4-A2FDA6DE3B4AQ36325841-1414FA13-28E0-4E99-9720-72A620A8A735Q36632212-C134C7AC-DAB0-4AB6-BB15-7CC5C751CE92Q37418917-7729A289-527A-4EB1-B528-CFF4A1007231Q37469045-69612E8B-02B9-438D-B816-FBABC23C57DDQ37486535-4DC062FF-66B2-41D8-B6E6-A26D6E1C1AF2Q37495847-3784BD85-FD57-436D-BEB0-F68DF72BB17DQ37587848-58D3A91A-BD4D-4ABF-90B5-9186682F0146Q37604753-35291E4D-5CA5-4371-A0F8-03EDA6B08770Q37690411-F1C0AAFA-E301-4CB7-BC17-25CA4CDA59A4Q38456502-47A20944-0C39-4699-BD8B-7D2C1A1B7C2FQ38862190-6A92C5C8-738E-418E-B456-A393F89EDBFEQ39864511-E87637B6-0D1B-4FFE-9B5D-76FB012F0147Q41341319-51F44620-1E28-4D73-8E9D-84EC44C9D693Q41960243-49AED85A-AC0F-44BC-B9D9-45243223BA8AQ43291657-BCFC83DE-1740-41E6-B719-7AD8F7ECF7E9
P2860
Association of kidney function with inflammatory and procoagulant markers in a diverse cohort: a cross-sectional analysis from the Multi-Ethnic Study of Atherosclerosis (MESA).
description
2008 nî lūn-bûn
@nan
2008 թուականի Օգոստոսին հրատարակուած գիտական յօդուած
@hyw
2008 թվականի օգոստոսին հրատարակված գիտական հոդված
@hy
2008年の論文
@ja
2008年論文
@yue
2008年論文
@zh-hant
2008年論文
@zh-hk
2008年論文
@zh-mo
2008年論文
@zh-tw
2008年论文
@wuu
name
Association of kidney function ...... udy of Atherosclerosis (MESA).
@ast
Association of kidney function ...... udy of Atherosclerosis (MESA).
@en
type
label
Association of kidney function ...... udy of Atherosclerosis (MESA).
@ast
Association of kidney function ...... udy of Atherosclerosis (MESA).
@en
prefLabel
Association of kidney function ...... udy of Atherosclerosis (MESA).
@ast
Association of kidney function ...... udy of Atherosclerosis (MESA).
@en
P2093
P2860
P356
P1433
P1476
Association of kidney function ...... udy of Atherosclerosis (MESA).
@en
P2093
Christopher Keller
Linda F Fried
Ronit Katz
P2860
P2888
P356
10.1186/1471-2369-9-9
P577
2008-08-05T00:00:00Z
P5875
P6179
1012218156